Partners
CHEP has direct and indirect funding from the Public Health Agency of Canada. CHEP has indirect funding from the Canadian Hypertension Society and Blood Pressure Canada. For the 2009 process, funding was received from the following corporate partners:
Astra Zeneca
Bayer Health Care
Biovail Pharma
Boehringer Ingelheim
Bristol-Myers Squibb
Merck Frosst Canada
Novartis
Pfizer
Sanofi-Aventis
Schering-Plough
Servier
CHEP also thanks the following sponsors for specific items:
Pfizer Canada – for the production of a summary pocket booklet
Servier Canada for the development of a patient self-care booklet
Pfizer Canada, Merck Frosst Canada, Sanofi-Aventis, Bristol-Myers Squibb and Servier Canada – for several epidemiological research projects.
The Public Health Agency of Canada, the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research – for their support of surveillance projects
Thanks to Bristol-Myers Squibb and Sanofi Aventis for assistance with the production of the spiral booklet.